Mechanism of Action and Clinical Applications of Cyclosporin in Organ Transplantation
- 1 June 1984
- journal article
- Published by Elsevier in Clinics in Immunology and Allergy
- Vol. 4 (2) , 217-258
- https://doi.org/10.1016/s0260-4639(22)00178-5
Abstract
No abstract availableThis publication has 66 references indexed in Scilit:
- REVERSAL OF TRANSPLANT REJECTION BY MONOCLONAL ANTIBLAST ANTIBODYThe Lancet, 1983
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983
- USE OF CYCLOSPORIN A IN ALLOGENEIC BONE MARROW TRANSPLANTATION FOR SEVERE APLASTIC ANEMIATransplantation, 1982
- Heart-Lung TransplantationNew England Journal of Medicine, 1982
- Nephrotoxicity of Cyclosporin a after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1981
- The relationship of cardiac output and arterial pressure control.Circulation, 1981
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- Immunosuppressive effects of Ovalicin-semicarbazoneInflammation Research, 1974
- Cardiac Transplantation in ManCirculation, 1970
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958